bioAffinity Technologies, Inc. Depreciation
bioAffinity Technologies, Inc. (BIAF) reported Depreciation of $23.11 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-07
- bioAffinity Technologies, Inc. depreciation for the quarter ending 2026-06-30 was $23.11K, a 48.03% decline year-over-year.
- bioAffinity Technologies, Inc. depreciation for the quarter ending 2026-03-31 was $24.41K, a 44.23% decline year-over-year.
- bioAffinity Technologies, Inc. depreciation for the quarter ending 2025-12-31 was $37.53K, a 12.33% decline year-over-year.
- bioAffinity Technologies, Inc. depreciation for the quarter ending 2025-09-30 was $44.60K, a 10.20% increase year-over-year.
- bioAffinity Technologies, Inc. depreciation for fiscal 2025 was $170.36K, a 4.94% increase from fiscal 2024.
- bioAffinity Technologies, Inc. depreciation for fiscal 2024 was $162.33K, a 30.35% decline from fiscal 2023.
- bioAffinity Technologies, Inc. depreciation for fiscal 2023 was $233.06K, a 2188.98% increase from fiscal 2022.
- bioAffinity Technologies, Inc. depreciation for fiscal 2022 was $10.18K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23.11K 10-Q · filed 2026-08-07 | $47.52K 10-Q · filed 2026-08-07 | $85.05K derived: sum of 3 quarters · filed 2026-08-07 | $129.64K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $24.41K 10-Q · filed 2026-05-11 | $61.94K derived: sum of 2 quarters · filed 2026-05-11 | $106.54K derived: sum of 3 quarters · filed 2026-05-11 | $151.00K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $37.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $82.13K derived: sum of 2 quarters · filed 2026-03-16 | $126.60K derived: sum of 3 quarters · filed 2026-08-07 | $170.36K 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $44.60K 10-Q · filed 2025-11-14 | $89.07K derived: sum of 2 quarters · filed 2026-08-07 | $132.83K 10-Q · filed 2025-11-14 | $175.64K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $44.47K 10-Q · filed 2026-08-07 | $88.23K 10-Q · filed 2026-08-07 | $131.04K derived: sum of 3 quarters · filed 2026-08-07 | $171.51K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $43.76K 10-Q · filed 2026-05-11 | $86.57K derived: sum of 2 quarters · filed 2026-05-11 | $127.04K derived: sum of 3 quarters · filed 2026-05-11 | $167.28K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $42.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $83.28K derived: sum of 2 quarters · filed 2026-03-16 | $123.52K derived: sum of 3 quarters · filed 2026-03-16 | $162.33K 10-K · filed 2026-03-16 | ||
| 2024-09-30 | $40.47K 10-Q · filed 2025-11-14 | $80.72K derived: sum of 2 quarters · filed 2025-11-14 | $119.53K 10-Q · filed 2025-11-14 | $285.81K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $40.24K 10-Q · filed 2025-08-14 | $79.05K 10-Q · filed 2025-08-14 | $245.34K derived: sum of 3 quarters · filed 2025-08-14 | $290.43K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $38.81K 10-Q · filed 2025-05-15 | $205.09K derived: sum of 2 quarters · filed 2025-05-15 | $250.19K derived: sum of 3 quarters · filed 2025-05-15 | $271.19K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $166.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $211.38K derived: sum of 2 quarters · filed 2025-03-31 | $232.38K derived: sum of 3 quarters · filed 2025-03-31 | $233.06K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $45.09K 10-Q · filed 2024-11-14 | $23.50K 10-Q · filed 2023-11-14 | $66.09K derived: sum of 2 quarters · filed 2024-11-14 | $66.78K 10-Q · filed 2024-11-14 | $66.80K 10-Q · filed 2023-11-14 | $95.06K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $21.00K 10-Q · filed 2024-08-14 | $41.00K 10-Q · filed 2024-08-14 | $49.97K derived: sum of 3 quarters · filed 2024-08-14 | $50.77K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $21.68K 10-Q · filed 2024-05-15 | $22.00K 10-Q · filed 2023-05-15 | $28.97K derived: sum of 2 quarters · filed 2024-05-15 | $29.77K derived: sum of 3 quarters · filed 2024-05-15 | $30.77K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $7.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $8.08K derived: sum of 2 quarters · filed 2024-04-01 | $9.08K derived: sum of 3 quarters · filed 2024-04-01 | $10.18K 10-K · filed 2024-04-01 | ||
| 2022-09-30 | $800.00 10-Q · filed 2023-11-14 | $1.80K derived: sum of 2 quarters · filed 2023-11-14 | $2.90K 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-14 | $2.00K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |